Clinical Trial Update: Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating genistein for localized prostate cancer in patients planning radical prostatectomy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Genistein (genistein)

Snippet

Sponsor: Northwestern University | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED